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Letter to the Editor
CD52+ regulatory T cells and
CD52-expressing sperms downregulated
in couples with unexplained infertility:
A case–control study
Dear Editor,
Unexplained infertility is a type of infertility with unknown reasons (1). Immunological
deregulations could be considered as a reason for this disorder. The immune
system is regulated by regulatory T cells (Treg) (2). Moreover, a deficiency in
the function or decreasing count of Treg cells may be the reason for some
unexplained infertilities. CD52 has been found to be expressed in Treg cells,
sperms, and seminal plasma and has an immunosuppressive function (3).
This study aimed to evaluate the expression of CD52 on Treg cells, sperm,
seminal plasma, and serum in a group of couples with unexplained infertility.
After the exclusion of maternal anatomic, hormonal, and paternal and maternal
chromosomal abnormalities, ten unexplained infertile (case group) and five
fertile couples (control group) were enrolled in this study. Semen and whole
blood samples were taken from the participants. The expression of CD52 on
the surface of Treg cells in peripheral blood mononuclear cells and sperm
cells was measured using flow cytometry. ELISA and Western blot tests were
used to examine CD52 levels in the serum and semen of the participants.
Furthermore, results were analyzed using the GraphPad Prism, version 5.0
software (Inc, USA). The Mann–Whitney test was used to compare the two
groups, whereas the Spearman test was used to determine their correlation.
A p-value less than 0.05 was considered statistically significant. There was
no difference regarding the percentage of CD52 expression in the sperm
cells between the case and control groups (p = 1). Moreover, CD52 intensity
in the sperm of case group men was lower than controls (p = 0.10). CD52
expression in Treg cells was lower among women (p = 0.54) and men (p =
0.07) in the case group compared to that of controls; however, it was not
statistically significant. The mean fluorescent intensity of CD52 in the semen of
infertile men was lower than fertile men (p = 0.10). Additionally, no differences
in CD52 levels were observed in the serum (221.3 ng/ml vs. 237 ng/ml) and
semen (191 ng/ml vs 175 ng/ml) among the case and control groups. Western
blot results showed no differences regarding CD52 expression in the sera or
semen between case and control groups (p = 0.017 and p = 0.16, respectively).
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Normal pregnancy is associated with high levels of Treg cells (4, 5) whereas deficiency of Treg
cells was related to unexplained infertility (6), miscarriage (7), and pre-eclampsia (8). A recent study
found that Treg cells that present high levels of CD52 have also shown regulatory properties
(9). This molecule is attached to its receptor named siglic-10, an inhibitory receptor that sends
an inhibitory signal (10). The levels of CD52 in the serum and semen and expression of CD52
by Treg cells might play a role in unexplained infertilities. The results of this study revealed
that the CD52 expression on the surface of the sperm of the infertile men was decreased
compared to that of the fertile men; however, the decrease was not statistically significant. The
results suggested that the decrease in CD52 expression in the sperm is a reason for the
less suppressive effect of the female reproductive system during the implantation in infertile
couples. Also, the percentages of CD3+ CD4+ FOXP3+ T cells expressing CD52 were decreased
in infertile men than in healthy men, with a trend toward a significant difference (p = 0.07).
Accordingly, these results showed that Treg cellsmay play an important role in maintaining a
normal pregnancy. Moreover, the result obtained from the correlation between the expressions
of CD52 in the serum and semen showed a positive significant correlation in fertile but not
in infertile men. This finding suggested that the balance in CD52 expression within the serum
and semen might affect the fertility outcome. The most crucial limitation of this study was
the small sample size. Increasing the sample size could give a greater potential to detect
significant differences. Based on the results of the present study examining the decreases levels
of Treg cells expressing CD52 molecules in unexplained male infertility and the CD52 receptor
(siglic-10) is suggested to understand the role of CD52 in the pathogenesis of unexplained
infertility.
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